Lacey J, Hewitt J, Daley-Morris JL, James J, Stevens J, Blaizel O. Expert clinical framework report: Management of adverse events related to novel therapies for relapsed/refractory multiple myeloma (RRMM). Can Hematol Today [Internet]. 2022 Nov. 15 [cited 2024 May 8];1(S11). Available from: https://canadianhematologytoday.com/article/view/30